Skip to main content Accessibility help
×
Home

BRAZILIAN HEALTH TECHNOLOGY ASSESSMENT BULLETIN: EDITORIAL PROCESS, DISSEMINATION STRATEGIES, CRITICAL APPRAISAL, AND INITIAL IMPACT

Abstract

Objectives: This study reports on the Brazilian experience of developing a specialized bulletin, the Brazilian Health Technology Assessment Bulletin (BRATS), on health technology assessments (HTA).

Methods: The editorial process, format, and dissemination strategy of the publication are presented. A critical appraisal of the available issues was made using the checklist for HTA reports of the International Network of Agencies for Health Technology Assessment. The initial impact was estimated based on a retrospective observational measurement of the types of publications that cite the bulletin as a source of information. The publications citing BRATS were identified using Google Scholar.

Results: Since June 2008, fourteen issues of the bulletin have been produced. BRATS has not presented any significant limitation that would compromise generalizations of its results within the Brazilian context. The initial impact of the bulletin, however, has been small, which may be due to its exclusively electronic dissemination format and technical language. We found nine publications citing BRATS in Google Scholar.

Conclusions: It is hoped that the bulletin will promote the continuity of HTA actions among health-sector managers and professionals in Brazil.

Copyright

References

Hide All
1.Atallah, AN. Evidence-based health technology assessments for the Brazilian National Health System (Sistema Único de Saúde, SUS) and for all. Sao Paulo Med J. 2009;127:5960.
2.Atallah, AN. Sources of evidence. Sao Paulo Med J. 2008;126:7374.
3.Athaydes, GA, Heineck, I, Lopes, EC. Análise de custos envolvendo medicamentos antes e após a cirurgia bariátrica. Porto Alegre: UFRGS; 2010.
4.Bahia. Secretaria da Administração. Protocolo Clínico e Diretrizes Terapêuticas para Tratamento da Degeneração Macular relacionada a Idade – DMRI. 1st ed. Salvador: SAEB/CGPS; 2009.
5.Banta, D, Almeira, RT. The development of health technology assessment in Brazil. Int J Technol Assess Health Care. 2009;25 (Suppl 1):255259.
6.Battista, RN, Hodge, MJ. The evolving paradigm of health technology assessment: Reflections for the millennium. CMAJ. 1999;160:14641467.
7.Brasil. Conselho Nacional de Secretários de Saúde. Relatório do Seminário Internacional de Assistência Farmacêutica do CONASS, realizado em 15 e 16 de junto de 2009, em Brasília/DF. Brasília: CONASS; 2010.
8.Brazilian Institute of Public Opinion and Statistics (IBOPE). The Nielsen Company. NetView. São Paulo: IBOPE Nielsen Online; 2010.
9.Bueno, RLP.A decisão de incorporação de tecnologias em saúde no SUS: A questão dos medicamentos. Porto Alegre: UFRGS; 2010.
10.Chamié, D, Abizaid, A. Stent Cronus: Chegou o momento de adotarmos um stent nacional? Rev Bras Cardiol Invas. 2009;17:300304.
11.Eisenberg, JM. Ten lessons for evidence-based technology assessment. JAMA. 1999;282:18651869.
12.Fattal, J, Lehoux, P. Health technology assessment use and dissemination by patient and consumer groups: Why and how? Int J Technol Assess Health Care. 2008;24:473480.
13.Goodman, C.HTA 101: Introduction to health technology assessment. Bethesda, MD: National Library of Medicine, National Information Center on Health Services Research and Health Care Technology; 2004.
14.Guioti, CO, Sander, GB, Araújo, MAM, Ronchini, MAK, Picon, PD, Santos, VCC. Boletim brasileiro de avaliação de tecnologias em saúde: Entecavir para o tratamento da hepatite B crônica. BRATS. 2006;1:16.
15.Hailey, D. Toward transparency in health technology assessment: A checklist for HTA reports. Int J Technol Assess Health Care. 2003;19:17.
16.Hanney, S, Buxton, M, Green, C, Coulson, D, Raftery, J. An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess. 2007;11: iii–iv, ix–xi, 1180.
17.International Society of Drug Bulletins. World Health Organization. Starting or strengthening a drug bulletin: A practical manual. Geneva: ISDB/WHO; 2005.
18.Kuruvilla, S, Mays, N, Pleasant, A, Walt, G. Describing the impact of health research: A Research Impact Framework. BMC Health Serv Res. 2006;6:134.
19.Lehoux, P, Tailliez, S, Denis, JL, Hivon, M. Redefining health technology assessment in Canada: Diversification of products and contextualization of findings. Int J Technol Assess Health Care. 2004;20:325336.
20.Nita, ME, Mantilla, P, Rahal, E, Araújo, ESA. Princípios da farmacoeconomia (FE) e análise farmacoeconômica do entecavir versus lamivudina em pacientes com hepatite B crônica no Brasil. In: Araújo, ESA. aBc das hepatites: Manual clínico para o manuseio, terapia e prevenção da hepatite B. São Paulo: Bristol-Myers Squibb; 2008.
21.Sancho, LG, Vargens, JMC. Health economic evaluation in a local level government health care system. Ciência & Saúde Coletiva. 2009;14 (Suppl 1):15131521.
22.Silva, MT. Sistema Único de Salud: La experiencia brasileña en la universalización del acceso a la salud. Rev Peru Med Exp Salud Publica. 2009;26:251257.
23.Watt, A, Cameron, A, Sturm, L, et al. Rapid reviews versus full systematic reviews: An inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care. 2008;24:133139.

Keywords

BRAZILIAN HEALTH TECHNOLOGY ASSESSMENT BULLETIN: EDITORIAL PROCESS, DISSEMINATION STRATEGIES, CRITICAL APPRAISAL, AND INITIAL IMPACT

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed